These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28440745)

  • 21. Pharmacokinetic interactions between primaquine and chloroquine.
    Pukrittayakamee S; Tarning J; Jittamala P; Charunwatthana P; Lawpoolsri S; Lee SJ; Hanpithakpong W; Hanboonkunupakarn B; Day NP; Ashley EA; White NJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3354-9. PubMed ID: 24687509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between Plasmodium vivax variants in Belém, Pará State, Brazil and symptoms and clearance of parasitaemia.
    Machado RL; de Figuereido Filho AF; Calvosa VS; Figueredo MC; Nascimento JM; Póvoa MM
    Braz J Infect Dis; 2003 Jun; 7(3):175-7. PubMed ID: 14499040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin.
    de Sena LWP; Mello AGNC; Ferreira MVD; de Ataide MA; Dias RM; Vieira JLF
    Malar J; 2019 Dec; 18(1):439. PubMed ID: 31864358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.
    de Santana Filho FS; Arcanjo AR; Chehuan YM; Costa MR; Martinez-Espinosa FE; Vieira JL; Barbosa Md; Alecrim WD; Alecrim Md
    Emerg Infect Dis; 2007 Jul; 13(7):1125-6. PubMed ID: 18214203
    [No Abstract]   [Full Text] [Related]  

  • 27. Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.
    Thanh PV; Hong NV; Van NV; Louisa M; Baird K; Xa NX; Peeters Grietens K; Hung le X; Duong TT; Rosanas-Urgell A; Speybroeck N; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7411-9. PubMed ID: 26392501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America.
    Phillips EJ; Keystone JS; Kain KC
    Clin Infect Dis; 1996 Nov; 23(5):1171-3. PubMed ID: 8922821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand.
    Tan-ariya P; Na-Bangchang K; Tin T; Limpaibul L; Brockelman CR; Karbwang J
    Trans R Soc Trop Med Hyg; 1995; 89(4):426-9. PubMed ID: 7570887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
    Pukrittayakamee S; Vanijanonta S; Chantra A; Clemens R; White NJ
    J Infect Dis; 1994 Apr; 169(4):932-5. PubMed ID: 8133114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan.
    Valibayov A; Abdullayev F; Mammadov S; Gasimov E; Sabatinelli G; Kondrachine AV; Ringwald P
    Acta Trop; 2003 Sep; 88(1):99-102. PubMed ID: 12943984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
    Fukuda MM; Krudsood S; Mohamed K; Green JA; Warrasak S; Noedl H; Euswas A; Ittiverakul M; Buathong N; Sriwichai S; Miller RS; Ohrt C
    PLoS One; 2017; 12(11):e0187376. PubMed ID: 29121061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
    López-Antuñano FJ
    Salud Publica Mex; 1999; 41(5):410-9. PubMed ID: 11142837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.
    Durand S; Cabezas C; Lescano AG; Galvez M; Gutierrez S; Arrospide N; Alvarez C; Santolalla ML; Bacon DJ; Graf PC
    Am J Trop Med Hyg; 2014 Jul; 91(1):18-26. PubMed ID: 24752682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium vivax malaria elimination: should innovative ideas from the past be revisited?
    Val FF; Sampaio VS; Cassera MB; Andrade RT; Tauil PL; Monteiro WM; Lacerda MV
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):522-4. PubMed ID: 25184997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Kristensen KL; Dragsted UB
    Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium vivax remains responsive to chloroquine with primaquine treatment regimen: a prospective cohort study from tertiary care teaching hospital in southern India.
    Saravu K; Acharya V; Kumar K; Kumar R
    Trop Doct; 2012 Jul; 42(3):163-4. PubMed ID: 22516030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.